Key result
Enteroviral proteases 2A and 3C drive tissue injury and cardiomyopathy by cleaving host proteins.
A deeper understanding of enteroviral protease interactions with host-cell proteins could facilitate the discovery of novel mechanisms contributing to diseases like myocarditis and identify new antiviral targets.
May support protease inhibition as antiviral strategy in enteroviral myocarditis; leaves open clinical translation pending prospective trials.
Enteroviruses are common human pathogens, and infections are particularly frequent in children. Severe infections can lead to a variety of diseases, including poliomyelitis, aseptic meningitis, myocarditis and neonatal sepsis. Enterovirus infections have also been implicated in asthmatic exacerbations and type 1 diabetes. The large disease spectrum of the closely related enteroviruses may be partially, but not fully, explained by differences in tissue tropism. The molecular mechanisms by which enteroviruses cause disease are poorly understood, but there is increasing evidence that the two enteroviral proteases, 2A(pro) and 3C(pro) , are important mediators of pathology. These proteases perform the post-translational proteolytic processing of the viral polyprotein, but they also cleave several host-cell proteins in order to promote the production of new virus particles, as well as to evade the cellular antiviral immune responses. Enterovirus-associated processing of cellular proteins may also contribute to pathology, as elegantly demonstrated by the 2A(pro) -mediated cleavage of dystrophin in cardiomyocytes contributing to Coxsackievirus-induced cardiomyopathy. It is likely that improved tools to identify targets for these proteases will reveal additional host protein substrates that can be linked to specific enterovirus-associated diseases. Here, we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication, including ways to avoid detection by the immune system. We also highlight new possibilities for the identification of protease-specific cellular targets and thereby a way to discover novel mechanisms contributing to disease.
No takes yet. Share an insight, caveat, or question.
Laitinen et al. (2016) conducted a review in Enterovirus infections. Enteroviral proteases 2A(pro) and 3C(pro) was evaluated. Enteroviral proteases 2A(pro) and 3C(pro) mediate pathology by cleaving host proteins to promote viral replication, evade immunity, and induce tissue damage like cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: